The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview (Q36410792)

14 August 2017

1 reference

MDMA

0 references

title

The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview (English)

1 reference

Euphrosyne Gouzoulis-Mayfrank

14 August 2017

Jörg Daumann

2

0 references

series ordinal

1

object named as

Euphrosyne Gouzoulis-Mayfrank

1 reference

PubMed ID

16510477

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Journal of Psychopharmacology

14 August 2017

1 reference

14 August 2017

20

1 reference

14 August 2017

2

1 reference

14 August 2017

188-193

1 reference

Memory impairment in abstinent MDMA ("Ecstasy") users.

14 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

The relative contributions of ecstasy and cannabis to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Neural correlates of working memory in pure and polyvalent ecstasy (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Exploring the association between cannabis use and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Mood state and brain electric activity in ecstasy users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Impaired cognitive performance in drug free users of recreational ecstasy (MDMA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy").

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cannabinoids and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cannabis use and psychotic disorders: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Comparison of cannabidiol, antioxidants, and diuretics in reversing binge ethanol-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cannabinoid receptor activation and elevated cyclic AMP reduce glutamate neurotoxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

The methamphetamine experience: a NIDA partnership

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cognitive efficiency in stimulant abusers with and without alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Amphetamine neurotoxicity: accomplishments and remaining challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cannabinoids and brain injury: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

The nature of ecstasy-group related deficits in associative learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Memory deficits associated with recreational use of "ecstasy" (MDMA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Recreational ecstasy/MDMA and other drug users from the UK and Italy: psychiatric symptoms and psychobiological problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cannabis use and mental health in young people: cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Neuropsychological performance in long-term cannabis users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Memory disturbances in "Ecstasy" users are correlated with an altered brain serotonin neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cortical serotonin transporter density and verbal memory in individuals who stopped using 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy"): preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I]beta-CIT SPECT study--preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cognitive performance amongst recreational users of "ecstasy".

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Differential effects of Ecstasy and cannabis on self-reports of memory ability: a web-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Relationship between ecstasy use and depression: a study controlling for poly-drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Is the use of ecstasy and hallucinogens increasing? Results from a community study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

The impact of regular ecstasy use on memory function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cognitive impairment in individuals currently using methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cognitive performance of current methamphetamine and cocaine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cognitive functioning of long-term heavy cannabis users seeking treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Cannabinoid receptors and their role in neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Acute neuronal injury, excitotoxicity, and the endocannabinoid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Differences in regional brain metabolism associated with marijuana abuse in methamphetamine abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Partial recovery of brain metabolism in methamphetamine abusers after protracted abstinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Working memory deficits in current and previous users of MDMA ('ecstasy').

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Deficient strategic control of verbal encoding and retrieval in individuals with methamphetamine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

Evidence for long-term neurotoxicity associated with methamphetamine abuse: A 1H MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881106059939

21 January 2018

Identifiers

DOI

10.1177/0269881106059939

1 reference

14 August 2017

1 reference

PubMed ID

16510477